TrialBMC cancer2018

Immune landscape and in vivo immunogenicity of NY-ESO-1 tumor antigen in advanced neuroblastoma patients.

Chiara Camisaschi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.